Počet záznamov: 1
mifepristón
SYS d015735 LBL 00000cz--a2200000o--4500 005 20250606214343.4 008 920906|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 $d BA006 065 $a D04.210.500.365.415.580 066 $a 01 $c 03 150 $a mifepristón $x AA $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo 550 $7 sllk_us_auth*d000021 $Y Abortifacient Agents, Steroidal $w P $a abortíva steroidné 550 $7 sllk_us_auth*d003280 $Y Contraceptives, Oral, Synthetic $w P $a kontraceptíva perorálne syntetické 550 $7 sllk_us_auth*d003283 $Y Contraceptives, Postcoital, Synthetic $w P $a prípravky antikoncepčné postkoitálne syntetické 550 $7 sllk_us_auth*d006727 $Y Hormone Antagonists $w P $a antagonisty hormónov 550 $7 sllk_us_auth*d008186 $Y Luteolytic Agents $w P $a látky luteolytické 550 $7 sllk_us_auth*d008600 $Y Menstruation-Inducing Agents $w P $a prípravky indukujúce menštruáciu 665 $a 90 $2 eng 665 $a Abortifacient Agents, Steroidal (1975-1989) $2 eng 665 $a Contraceptives, Oral, Synthetic (1975-1989) $2 eng 665 $a Estrenes (1975-1989) $2 eng 665 $a Glucocorticoids/antagonists & inhibitors (1967-1989) $2 eng 680 9-
$i A progestational and glucocorticoid hormone antagonist. Its inhibition of progesterone induces bleeding during the luteal phase and in early pregnancy by releasing endogenous prostaglandins from the endometrium or decidua. As a glucocorticoid receptor antagonist, the drug has been used to treat hypercortisolism in patients with nonpituitary CUSHING SYNDROME. $2 eng 750 -2
$a Mifepristone $2 eng 980 $x M
Počet záznamov: 1